|
US4012A
(en)
*
|
|
1845-04-26 |
|
Improvement in electrographic printing |
|
US4235871A
(en)
*
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
JPS5938877A
(ja)
*
|
1982-08-30 |
1984-03-02 |
Musashi Eng Kk |
紙葉判別方法
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4599230A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4599231A
(en)
*
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4957735A
(en)
*
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
|
US5019369A
(en)
*
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4608251A
(en)
*
|
1984-11-09 |
1986-08-26 |
Pitman-Moore, Inc. |
LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
|
|
US4601903A
(en)
*
|
1985-05-01 |
1986-07-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
WO1988001649A1
(en)
|
1986-09-02 |
1988-03-10 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5055303A
(en)
*
|
1989-01-31 |
1991-10-08 |
Kv Pharmaceutical Company |
Solid controlled release bioadherent emulsions
|
|
US5271961A
(en)
*
|
1989-11-06 |
1993-12-21 |
Alkermes Controlled Therapeutics, Inc. |
Method for producing protein microspheres
|
|
US5188837A
(en)
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
|
ES2284161T3
(es)
|
1990-01-12 |
2007-11-01 |
Amgen Fremont Inc. |
Generacion de anticuerpos xenogenicos.
|
|
US5268164A
(en)
*
|
1990-04-23 |
1993-12-07 |
Alkermes, Inc. |
Increasing blood-brain barrier permeability with permeabilizer peptides
|
|
US5661016A
(en)
*
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
*
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
*
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
*
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
AU8507191A
(en)
|
1990-08-29 |
1992-03-30 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
FR2670787B1
(fr)
|
1990-12-18 |
1995-06-23 |
Pasteur Institut |
Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins.
|
|
US5871746A
(en)
|
1990-12-18 |
1999-02-16 |
Institut National De La Sainte Et De La Recherche Medicale (Inserm) |
Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines
|
|
US5254342A
(en)
|
1991-09-30 |
1993-10-19 |
University Of Southern California |
Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
|
|
EP0630234B1
(en)
*
|
1992-03-12 |
1997-06-11 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release acth containing microspheres
|
|
US5534496A
(en)
|
1992-07-07 |
1996-07-09 |
University Of Southern California |
Methods and compositions to enhance epithelial drug transport
|
|
DE4233152A1
(de)
*
|
1992-10-02 |
1994-04-07 |
Behringwerke Ag |
Antikörper-Enzym-Konjugate zur Prodrug-Aktivierung
|
|
ATE153380T1
(de)
*
|
1993-01-16 |
1997-06-15 |
Manfred Schawaller |
Verfahren zur gewinnung nativer, oligomerer, glykosylierter ektodomänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv
|
|
US5514670A
(en)
*
|
1993-08-13 |
1996-05-07 |
Pharmos Corporation |
Submicron emulsions for delivery of peptides
|
|
US6040137A
(en)
*
|
1995-04-27 |
2000-03-21 |
Tripep Ab |
Antigen/antibody specification exchanger
|
|
US5888773A
(en)
|
1994-08-17 |
1999-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of producing single-chain Fv molecules
|
|
US6440418B1
(en)
*
|
1995-11-07 |
2002-08-27 |
Idec Pharmaceuticals Corporation |
Methods of treating autoimmune diseases with gp39-specific antibodies
|
|
EP1033406A4
(en)
|
1997-10-27 |
2005-03-09 |
Sumitomo Electric Industries |
INDUCER FOR THE PRODUCTION OF ANTIGEN-SPECIFIC ANTIBODY, EXPRESSION VECTOR CONTAINING THE GENE REQUIRED THEREFOR, AND METHOD FOR INDUCING THE PRODUCTION OF THE ANTIGEN-SPECIFIC ANTIBODY
|
|
FR2771640B1
(fr)
|
1997-12-03 |
2000-02-11 |
Inst Nat Sante Rech Med |
Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques
|
|
US6541011B2
(en)
|
1998-02-11 |
2003-04-01 |
Maxygen, Inc. |
Antigen library immunization
|
|
KR100797876B1
(ko)
*
|
1998-04-07 |
2008-01-24 |
코릭사 코포레이션 |
마이코박테리움 튜베르쿨로시스 항원의 융합 단백질 및이의 용도
|
|
WO1999055715A2
(en)
*
|
1998-04-28 |
1999-11-04 |
Galenica Pharmaceuticals, Inc. |
Polysaccharide-antigen conjugates
|
|
US6946129B1
(en)
|
1999-06-08 |
2005-09-20 |
Seattle Genetics, Inc. |
Recombinant anti-CD40 antibody and uses thereof
|
|
EP1246643A4
(en)
|
1999-10-14 |
2005-05-11 |
Jeffery A Ledbetter |
DNA VACCINES ENCODING ANTIGEN ASSOCIATED WITH CD40-BINDING DOMAIN
|
|
GB9926084D0
(en)
|
1999-11-03 |
2000-01-12 |
King S College London |
Recombinant fusion molecules
|
|
DE60136334D1
(en)
|
2000-02-02 |
2008-12-11 |
Us Health |
Cd40-ligand als adjuvant für respiratorisches syncytialvirus-impfstoff
|
|
AU2001259215A1
(en)
*
|
2000-04-28 |
2001-11-12 |
La Jolla Institute For Allergy And Immunology |
Human anti-cd40 antibodies and methods of making and using same
|
|
US20030059427A1
(en)
*
|
2000-04-28 |
2003-03-27 |
Force Walker R. |
Isolation and characterization of highly active anti-CD40 antibody
|
|
KR100643818B1
(ko)
|
2000-05-08 |
2006-11-10 |
셀덱스 쎄라퓨틱스, 인크. |
수상세포에 대한 인간 모노클로날 항체
|
|
US7560534B2
(en)
|
2000-05-08 |
2009-07-14 |
Celldex Research Corporation |
Molecular conjugates comprising human monoclonal antibodies to dendritic cells
|
|
US20030232055A1
(en)
|
2000-07-31 |
2003-12-18 |
Ruslan Medzhitov |
Innate immune system-directed vaccines
|
|
WO2002028905A2
(en)
*
|
2000-10-02 |
2002-04-11 |
Chiron Corporation |
Human anti-cd40 antibodies
|
|
JP4025881B2
(ja)
|
2001-04-27 |
2007-12-26 |
キリンファーマ株式会社 |
抗ｃｄ４０モノクローナル抗体
|
|
EP2011802A3
(en)
*
|
2001-04-27 |
2009-04-15 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-CD40 monoclonal antibody
|
|
CA2492823A1
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
WO2003029296A1
(en)
*
|
2001-10-02 |
2003-04-10 |
Chiron Corporation |
Human anti-cd40 antibodies
|
|
AR039067A1
(es)
*
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
US20080199471A1
(en)
*
|
2002-03-01 |
2008-08-21 |
Bernett Matthew J |
Optimized cd40 antibodies and methods of using the same
|
|
FR2837104B1
(fr)
|
2002-03-14 |
2004-08-06 |
Dev Des Antigenes Combinatoire |
Utilisation de melange de lipopeptides pour la fabrication de vaccins
|
|
EP1551453A4
(en)
*
|
2002-06-17 |
2007-04-25 |
Us Gov Health & Human Serv |
SPECIFICITY GRAFTING OF A MICE RESPONSE TO A HUMAN FRAME
|
|
US8025873B2
(en)
*
|
2002-06-20 |
2011-09-27 |
Paladin Labs, Inc. |
Chimeric antigens for eliciting an immune response
|
|
CN100381463C
(zh)
*
|
2002-09-18 |
2008-04-16 |
中国人民解放军免疫学研究所 |
用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途
|
|
US20040146948A1
(en)
|
2002-10-18 |
2004-07-29 |
Centenary Institute Of Cancer Medicine And Cell Biology |
Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments
|
|
JP2004192125A
(ja)
|
2002-12-09 |
2004-07-08 |
Mitsue-Links Co Ltd |
プロジェクトマネジメントシステム及びそれに用いられるデータ構造、並びに、プロジェクトマネジメント方法
|
|
GB0228796D0
(en)
|
2002-12-11 |
2003-01-15 |
Adjuvantix Ltd |
Valency
|
|
KR20050099536A
(ko)
|
2003-02-06 |
2005-10-13 |
트리펩 아베 |
글리코실화된 특이성 교환체
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
US8277810B2
(en)
*
|
2003-11-04 |
2012-10-02 |
Novartis Vaccines & Diagnostics, Inc. |
Antagonist anti-CD40 antibodies
|
|
KR101223373B1
(ko)
|
2003-12-25 |
2013-01-16 |
교와 핫꼬 기린 가부시키가이샤 |
항 ｃｄ４０ 항체의 변이체
|
|
WO2006002438A2
(en)
*
|
2004-06-03 |
2006-01-05 |
Medarex, Inc. |
Human monoclonal antibodies to fc gamma receptor i (cd64)
|
|
EP1877087B1
(en)
|
2005-04-15 |
2013-02-20 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
|
|
EP1885399B1
(en)
|
2005-05-26 |
2010-10-20 |
Seattle Genetics, Inc. |
Humanized anti-cd40 antibodies and their methods of use
|
|
JP2007026135A
(ja)
|
2005-07-19 |
2007-02-01 |
Shimizu Corp |
プログラムマネジメントチャート作成支援システム
|
|
CA2620667A1
(en)
*
|
2005-08-30 |
2007-04-12 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity
|
|
JP2009511024A
(ja)
|
2005-10-13 |
2009-03-19 |
ヴィレックス メディカル コーポレイション |
免疫応答を誘導するためのＣ型肝炎ウイルスポリペプチドおよびＦｃフラグメントを含むキメラ抗原
|
|
SG166788A1
(en)
|
2005-10-28 |
2010-12-29 |
Centocor Inc |
Use of b cell expansion agents in generating antibodies
|
|
WO2007103048A2
(en)
*
|
2006-03-01 |
2007-09-13 |
Regents Of The University Of Colorado |
Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
|
|
EP2589654A1
(en)
*
|
2006-05-03 |
2013-05-08 |
The Regents of the University of Colorado, a body corporate |
CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
|
|
US7804955B2
(en)
|
2006-06-21 |
2010-09-28 |
Sony Ericsson Mobile Communications Ab |
Flexible key plate
|
|
NZ601022A
(en)
|
2006-10-12 |
2014-09-26 |
Chugai Pharmaceutical Co Ltd |
Diagnosis and treatment of cancer using anti-ereg antibody
|
|
US20080241139A1
(en)
*
|
2006-10-31 |
2008-10-02 |
Regents Of The University Of Colorado |
Adjuvant combinations comprising a microbial tlr agonist, a cd40 or 4-1bb agonist, and optionally an antigen and the use thereof for inducing a synergistic enhancement in cellular immunity
|
|
MX2009008140A
(es)
*
|
2007-02-02 |
2009-10-26 |
Baylor Res Inst |
Vacunas a base de antigeno dirigido a dcir expresado en celulas que presentan antigeno.
|
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
|
|
NZ578657A
(en)
|
2007-02-02 |
2012-02-24 |
Baylor Res Inst |
Multivariable antigens complexed with targeting humanized monoclonal antibody
|
|
DK2160401T3
(da)
|
2007-05-11 |
2014-10-20 |
Altor Bioscience Corp |
Fusionsmolekyler og il-15-varianter
|
|
US20090023822A1
(en)
*
|
2007-07-19 |
2009-01-22 |
Tijm Peter J |
Method for activating and regenerating catalyst for a fischer-tropsch synthesis reaction
|
|
JP5233505B2
(ja)
|
2008-03-17 |
2013-07-10 |
株式会社リコー |
共同作業支援装置、共同作業支援システム、共同作業支援方法、プログラムおよび記録媒体
|
|
KR20110036618A
(ko)
|
2008-07-16 |
2011-04-07 |
베일러 리서치 인스티튜트 |
극대화된 Ｇａｇ 및 Ｎｅｆ를 수지상 세포에 표적화시킴을 기본으로 하는 ＨＩＶ 백신
|
|
US8518410B2
(en)
*
|
2009-03-10 |
2013-08-27 |
Baylor Research Institute |
Fusion protein with HIV antigen
|
|
EP2406288B1
(en)
*
|
2009-03-10 |
2016-12-14 |
Baylor Research Institute |
Antigen presenting cell targeted vaccines
|
|
AU2010222942B2
(en)
|
2009-03-10 |
2013-01-10 |
Baylor Research Institute |
Anti-CD40 antibodies and uses thereof
|
|
JP2013503140A
(ja)
*
|
2009-08-27 |
2013-01-31 |
ノヴォ ノルディスク アー／エス |
活性化血小板に対する組織因子の標的化
|
|
AU2010291939B2
(en)
|
2009-09-14 |
2012-11-15 |
Baylor Research Institute |
Vaccines directed to Langerhans cells
|
|
MX2012012833A
(es)
|
2010-05-07 |
2012-11-30 |
Baylor Res Inst |
Cebado cruzado de celulas t cd8 positivas humanos moderada por inmunoreceptores de celulas dendriticas (dcir).
|
|
JP2012052007A
(ja)
|
2010-08-31 |
2012-03-15 |
Fujifilm Corp |
環状リンカーボネート化合物、難燃剤、樹脂組成物、及び電気電子機器用筐体
|
|
WO2012129227A1
(en)
*
|
2011-03-22 |
2012-09-27 |
Baylor Research Institute |
Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine
|
|
JP2014157365A
(ja)
*
|
2014-04-30 |
2014-08-28 |
Canon Inc |
電子写真画像形成装置
|